These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 21820873

  • 1. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C.
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [Abstract] [Full Text] [Related]

  • 2. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
    El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, El Barbary NS, Nassef NM.
    Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H, Genc BO, Dogan EA, Genc E, Ozdemir S.
    Gynecol Obstet Invest; 2009 Sep; 67(4):223-7. PubMed ID: 19246930
    [Abstract] [Full Text] [Related]

  • 4. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L, Meo R.
    Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
    [Abstract] [Full Text] [Related]

  • 5. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauer G.
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [Abstract] [Full Text] [Related]

  • 6. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S, Sahota P, Kharbanda PS, Siali R, Jain V, Lal V, Khurana D.
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [Abstract] [Full Text] [Related]

  • 7. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication.
    Löfgren E, Mikkonen K, Tolonen U, Pakarinen A, Koivunen R, Myllyla VV, Tapanainen JS, Isojärvi JI.
    Epilepsy Behav; 2007 Feb; 10(1):77-83. PubMed ID: 17098479
    [Abstract] [Full Text] [Related]

  • 8. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
    Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS.
    Biol Psychiatry; 2006 Jun 01; 59(11):1078-86. PubMed ID: 16448626
    [Abstract] [Full Text] [Related]

  • 9. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.
    Fertil Steril; 2009 Dec 01; 92(6):1960-5. PubMed ID: 18980763
    [Abstract] [Full Text] [Related]

  • 10. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
    Sahota P, Prabhakar S, Kharbanda PS, Bhansali A, Jain V, Das CP, Modi M.
    Epilepsia; 2008 Dec 01; 49(12):2069-77. PubMed ID: 18503558
    [Abstract] [Full Text] [Related]

  • 11. Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis.
    Zhang L, Li H, Li S, Zou X.
    Eur J Obstet Gynecol Reprod Biol; 2016 Jul 01; 202():26-31. PubMed ID: 27160812
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV.
    N Engl J Med; 1993 Nov 04; 329(19):1383-8. PubMed ID: 8413434
    [Abstract] [Full Text] [Related]

  • 13. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS, Srinivasa R, Sadhotra A.
    Epilepsy Res; 2018 Jan 04; 139():20-27. PubMed ID: 29144993
    [Abstract] [Full Text] [Related]

  • 14. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine.
    Morrell MJ, Hayes FJ, Sluss PM, Adams JM, Bhatt M, Ozkara C, Warnock CR, Isojärvi J.
    Ann Neurol; 2008 Aug 04; 64(2):200-11. PubMed ID: 18756476
    [Abstract] [Full Text] [Related]

  • 15. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ.
    Epilepsia; 2001 Aug 04; 42(8):1002-6. PubMed ID: 11554885
    [Abstract] [Full Text] [Related]

  • 16. On the association between valproate and polycystic ovary syndrome.
    Genton P, Bauer J, Duncan S, Taylor AE, Balen AH, Eberle A, Pedersen B, Salas-Puig X, Sauer MV.
    Epilepsia; 2001 Mar 04; 42(3):295-304. PubMed ID: 11442143
    [Abstract] [Full Text] [Related]

  • 17. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 04; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 18. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H.
    Epilepsia; 2007 Mar 04; 48(3):470-7. PubMed ID: 17326798
    [Abstract] [Full Text] [Related]

  • 19. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2008 Aug 04; 23(8):1924-31. PubMed ID: 18579512
    [Abstract] [Full Text] [Related]

  • 20. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V, Pakarinen A, Knip M, Isojärvi J.
    Epilepsy Behav; 2006 May 04; 8(3):643-8. PubMed ID: 16600693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.